Congenital heart disease is usually diagnosed in babies—and often requires time-sensitive surgery. But did you know that even after a childhood procedure to correct the heart's structure, most patients will need specialized treatment as ...
Meet William Shion, surgical technologist at Cedars-Sinai. We talked to William about what it's like to be in the operating room during cardiac surgery, his journey to Cedars-Sinai and what it takes to become a surgical tech.
Dr. Danny Ramzy uses minimally invasive techniques for heart surgery whenever possible and has an exceptional record. Cedars-Sinai patient, Whitney Kell explains why Dr. Danny Ramzy was the best surgeon for her heart condition.
Research around the link between cognitive health and heart health is growing, with recommendations increasingly mirroring each other. A better understanding could create more targeted care and ultimately reduce dementia risk.
Dr. Trento grew up in Italy, and the love of his life, Robin, spent much of the first year of their marriage learning about one of his other great loves: his mother's cooking. Versions of those recipes—now with Robin's own flair—still ...
Meet Dr. Peng-Sheng Chen, a cardiologist at Cedars-Sinai! Dr. Chen, the Burns and Allen Chair in Cardiology Research, talks about his journey from Taiwan to Cedars-Sinai and his career in electrophysiology.
Meet Dr. Raj Makkar, associate director of Interventional Technologies at the Smidt Heart Institute! Learn about his journey here from India, his favorite parts of his job and what he likes to do outside of the hospital.
The best aortic dissection treatment results are achieved in centers that provide a dedicated service, like Cedars-Sinai. An experienced team is vital to the success of the necessary lifesaving procedure.
Cedars-Sinai received the top rating from the Society of Thoracic Surgeons for mitral surgery again this year and is supporting new initiatives to help patients and their physicians find expert mitral repair centers and surgeons locally.
New guidelines published in the 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease impact treatment of chronic, severe functional mitral regurgitation and anticoagulation in valvular heart disease.